International Technologies Marketing, Inc. v. Cognyte Technologies Israel Ltd.

CourtDistrict Court, S.D. New York
DecidedOctober 19, 2022
Docket1:15-cv-02457
StatusUnknown

This text of International Technologies Marketing, Inc. v. Cognyte Technologies Israel Ltd. (International Technologies Marketing, Inc. v. Cognyte Technologies Israel Ltd.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
International Technologies Marketing, Inc. v. Cognyte Technologies Israel Ltd., (S.D.N.Y. 2022).

Opinion

UNITED STATES DISTRICT COURT ELECTRONICALLY FILED DOC #: _________________ SOUTHERN DISTRICT OF NEW YORK DATE FILED: 10/19/2022 --------------------------------------------------------------- X : INTERNATIONAL TECHONOLOGIES : MARKETING, INC., : : 1:15-cv-2457-GHW Plaintiff, : -against- : MEMORANDUM OPINION & : ORDER COGNYTE TECHNOLOGIES ISRAEL LTD., : : Defendant. : -------------------------------------------------------------- X

GREGORY H. WOODS, United States District Judge:

I. INTRODUCTION For years, plaintiff International Technologies Marketing, Inc. (“Plaintiff” or “ITM”) pursued defendant Cognyte Technologies Israel Ltd., formerly known as Verint Systems, Ltd. (“Defendant” or “Cognyte”), for allegedly failing to compensate ITM for advising services it provided between 2006 and 2007 in connection with a potential acquisition. What began as a straightforward contract dispute has become a six-year odyssey for Cognyte. Several years of that odyssey stemmed directly from ITM’s bad-faith pursuit of a frivolous quantum meruit claim. As a result, Cognyte has asked the Court to impose monetary sanctions against ITM and its principal, Anthony Schehtman, for litigation misconduct under both the Court’s inherent authority and Rule 11. For the reasons set forth below, the Court grants Cognyte’s motion to impose sanctions pursuant to its inherent authority but denies—under a plain-text reading of Rule 11—Cognyte’s motion for Rule 11 sanctions. II. BACKGROUND The Court presumes the reader’s familiarity with this case. The facts are described in several of the Court’s previous orders. See Int’l Techs. Mktg., Inc. v. Verint Sys., Ltd., 157 F. Supp. 3d 352, 357 (S.D.N.Y. 2016); Int’l Techs. Mktg., Inc. v. Verint Sys., Ltd., No. 1:15-cv-2457, 2019 WL 1245013, at *1 (S.D.N.Y. Mar. 18, 2019), aff’d, 850 F. App’x 38 (2d Cir. 2021) (summary order). What follows are the facts and procedural history that are particularly relevant to Cognyte’s motions for sanctions. See Dkt. Nos. 80–82, 218–21, 285–86. ITM filed its initial complaint in March 2015, asserting various contractual and quasi- contractual claims against Cognyte. Dkt. No. 1. The complaint’s basic allegations centered on Cognyte’s alleged failure to compensate ITM for advising services related to work on a potential

acquisition. Id. at ¶¶ 67–90. Most relevant here, ITM asserted that it should be compensated for $350,000 in costs that it had incurred during the period of its engagement under a claim of unjust enrichment, or in the alternative, under a claim of quantum meruit. Id. ¶¶ 84–85. Specifically, ITM alleged that it incurred $350,000 in costs while promoting Cognyte’s entry into the Brazilian business and government markets, principally through the acquisition of Suntech, another technology company. Id. ¶ 85. ITM then filed an amended complaint (the “FAC”) in July 2015. Dkt. No. 27. In the FAC, ITM reasserted its prior contract and quasi-contract claims—including the claim for unjust enrichment or quantum meruit—and added one additional claim. See id. ¶¶ 77–113. In January 2016, the Court dismissed the FAC in its entirety. Dkt. No. 52. As to the unjust enrichment or quantum meruit claim, the Court reasoned that ITM could not recover under a quasi-contractual theory for the same damages that it sought under a valid (though expired) 2006–2007 contract,

which precluded relief on that basis. Id. at 22–24. The Court, however, permitted ITM to replead its unjust enrichment or quantum meruit claim, while cautioning that any such claim must be limited to ITM’s efforts after the expiration of the contract. Id. at 24. ITM filed a second amended complaint (the “SAC”) in February 2016. Dkt. No. 62. The SAC asserted claims for breach of contract, unjust enrichment or quantum meruit, and breach of an implied-in-fact contract. Id. ¶¶ 84–109. Cognyte asked the Court for permission to move to dismiss this complaint and to file a motion for sanctions, arguing that ITM could not replead a contract claim that was dismissed by the Court with prejudice. Dkt. No. 67. Before the Court acted on that request, ITM filed a third amended complaint (the “TAC”), which abandoned the breach of contract claim, but restated the unjust enrichment or quantum meruit claim and the breach of an implied-in- fact contract claim. Dkt. No. 73 ¶¶ 84–95. In April 2016, Cognyte moved to dismiss the TAC. Dkt. Nos. 77–78. It also requested that

the Court impose sanctions under Rule 11. Dkt. Nos. 80–82. In its sanctions motion, Cognyte observed that the quantum meruit claim in the TAC sought $350,000 for services rendered on Cognyte’s behalf after the contract expired, while the quantum meruit claims asserted in the FAC sought an identical amount for efforts that it appeared to allege were undertaken before and after the contract expired. Dkt. No. 82 at 11–12; compare FAC ¶ 76 (noting simply that “ITM incurred expenses on [a] project totaling approximately $350,000”), with TAC ¶ 83 (alleging that “after February 2007, ITM incurred expenses on [a] project totaling approximately $350,000” (emphasis added)). The Court dismissed ITM’s breach of implied-in-fact contract claim. Dkt. No. 92 at 8:1–7. The Court, however, allowed ITM to pursue its quantum meruit claim because Plaintiff “ha[d] represented” that “the TAC’s claims for unjust enrichment” were limited to the period after the parties’ express contract was in effect; the Court was required to “accept the allegations in the TAC as true for these purposes.” Id. at 9:11–10:6. The Court also denied Cognyte’s Rule 11 motion

because it did “not have sufficient information at [the] time to conclude that counsel ha[d] violated his Rule 11 obligations.” Id. at 12:12 14. After the Court’s decision on– the motion to dismiss, the parties engaged in discovery related to ITM’s quantum meruit claim for the post-contractual period—the only claim remaining in the case. Discovery was contentious. ITM delayed document production and forced Cognyte to review thousands of irrelevant documents. Dkt. No. 221 at 7. ITM required eight extensions to complete its document production. Id. ITM also represented that a neurological injury prevented Mr. Schehtman from traveling to New York for his deposition even as he traveled to Israel to meet with potential witnesses for this case. Id. at 23–24; see Dkt. No. 124. During a conference call in October 2017, Cognyte’s counsel and ITM’s then-counsel discussed the difficulty and delay in scheduling Mr. Schehtman’s deposition. See Dkt. No. 220, Declaration of Howard I. Elman in Support of Verint’s Motion to Renew and Motion for Sanctions (the “Elman Decl.”) ¶ 5. Mr. Schehtman was deposed

in January 2018, one year after Cognyte served deposition notices on him. See Dkt. Nos. 124 at 1, 152 at 7:9–10. Mr. Schehtman’s deposition testimony and related documents produced in discovery were startling. Mr. Schehtman admitted that—despite ITM’s claim that it had regularly communicated with high-level stakeholders and executives (the “Proxies”) at Cognyte during the post-contractual period, see TAC ¶¶ 70–71—he did not actually know whether any of the supposed Proxies actually worked for Cognyte. See Elman Decl. Ex. 3 at 299:11–302:2, 304:19–308:6, 74:12–75:17. Mr. Schehtman’s testimony and other documents also revealed that Schehtman, far from working on Cognyte’s behalf in the post-contractual period (as would be necessary to support a quantum meruit claim) instead worked against Cognyte’s interests by assisting Cognyte’s competitors during that time. See Elman Decl. Ex. 4 at 375:16–22. Mr. Schehtman stated that he intended to give Cognyte a “bloody nose,” id. at 389:17, and explained that he treated Cognyte as the enemy at certain points in

time, id. at 394:16 18. In a May 2008 email to Suntech, Cognyte’s then-competitor, Mr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Hensley v. Eckerhart
461 U.S. 424 (Supreme Court, 1983)
Blum v. Stenson
465 U.S. 886 (Supreme Court, 1984)
Chambers v. Nasco, Inc.
501 U.S. 32 (Supreme Court, 1991)
Oliveri v. Thompson
803 F.2d 1265 (Second Circuit, 1986)
Sassower v. Field
973 F.2d 75 (Second Circuit, 1992)
Enmon v. Prospect Capital Corp.
675 F.3d 138 (Second Circuit, 2012)
Sternberg v. Fletcher
143 F.3d 748 (Second Circuit, 1998)
Ransmeier v. UAL Corporation
718 F.3d 64 (Second Circuit, 2013)
Simmons v. New York City Transit Authority
575 F.3d 170 (Second Circuit, 2009)
De Jesus-Keolamphu v. Village of Pelham Manor
999 F. Supp. 556 (S.D. New York, 1998)
Int'l Techs. Mktg., Inc. v. Verint Sys., Ltd.
991 F.3d 361 (Second Circuit, 2021)
Gierlinger v. Gleason
160 F.3d 858 (Second Circuit, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
International Technologies Marketing, Inc. v. Cognyte Technologies Israel Ltd., Counsel Stack Legal Research, https://law.counselstack.com/opinion/international-technologies-marketing-inc-v-cognyte-technologies-israel-nysd-2022.